• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERPORT ISP M.R.I. IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERPORT ISP M.R.I. IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number 1808560
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Embolism (1498); Cardiac Arrest (1762); Thrombosis/Thrombus (4440); Insufficient Information (4580)
Event Date 08/20/2019
Event Type  Death  
Manufacturer Narrative
H10: date of death for this patient was not provided, date of death updated as (b)(6) 1900 for the mdr submission requirement.H10: as the lot number for the device was not provided, a review of the device history records could not be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Event Description
It was reported through the litigation process that sometime post a port placement, the patient was allegedly diagnosed with thrombosis.It was further reported that the patient reportedly expired.Furthermore, there was no specific device malfunction reported that may or may not have caused or contributed to the patient¿s death.The cause of the patient¿s death was not provided.No other pertinent patient, device or medical information was provided leading up to or surrounding the event.
 
Event Description
It was reported through the litigation process that a port was placed in a patient after being diagnosed with non-small cell carcinoma of lung.Two weeks and five days post a port placement via the right internal jugular vein, it was alleged that the patient was diagnosed with thrombosis and pulmonary embolism in the left upper lobe.The device has not been removed and there were no reported attempts made to retrieve the port.However, the patient reportedly expired due to cardiopulmonary arrest and the relationship of the death with the device is unknown at this time.
 
Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H10: d4 (expiry date: 01/2022), g2, g3.H11: b2, b3, b5, d1, d4, d6 (medical device implant date), h6 (patient).H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Event Description
It was reported through the litigation process that a port was placed in a patient after being diagnosed with non-small cell carcinoma of lung.Two weeks and five days post a port placement via the right internal jugular vein, it was alleged that the patient was diagnosed with thrombosis and pulmonary embolism in the left upper lobe.The device has not been removed and there were no reported attempts made to retrieve the port.Reportedly, the patient got expired due to cardiopulmonary arrest and the relationship of the death with the device was unknown.
 
Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.The medical record review found the patient experienced chest pain and subsegmental pulmonary embolism in the left upper lobe.The death certificate was received, indicating that the patient was expired and the reason for death was cardiopulmonary arrest.Therefore chest pain, pulmonary embolism, cardiopulmonary arrest, and death are confirmed.The reported shortness of breath, cough, and intermittent hemoptysis, although they could be related to the pulmonary embolism, cannot be confirmed since they were not included in the medical record review.A definitive root cause for these events, including their relationship to the port device, could not be determined based upon the provided information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.The instructions for use was reviewed: in particular, a review of this instructions for use found that embolism and thrombosis are known serious complications for the use of this device."possible complications the use of a subcutaneous port provides an important means of venous access for critically ill patients.However, the potential exists for serious complications, including the following: thromboembolism.Vascular thrombosis".H10: d4 (expiration date: 01/2022), g3, h6 (method).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERPORT ISP M.R.I. IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key18693714
MDR Text Key335184989
Report Number3006260740-2024-00486
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741027116
UDI-Public(01)00801741027116
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K063377
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer,Health Professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 04/30/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1808560
Device Lot NumberREDS1463
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/18/2024
Initial Date FDA Received02/13/2024
Supplement Dates Manufacturer Received03/12/2024
04/30/2024
Supplement Dates FDA Received04/09/2024
05/06/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/21/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age60 YR
Patient SexFemale
Patient Weight74 KG
Patient RaceBlack Or African American
-
-